Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for Injection

About this update from Shanghai Allist Pharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of AST2169 Liposome for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:" target="_blank">View Attachment

View stock analysis, news, and events for Shanghai Allist Pharmaceuticals Co. Ltd. Class A